• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对苯二酚单苄醚。18例白癜风患者治疗的回顾性研究及文献综述。

Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature.

作者信息

Mosher D B, Parrish J A, Fitzpatrick T B

出版信息

Br J Dermatol. 1977 Dec;97(6):669-79. doi: 10.1111/j.1365-2133.1977.tb14275.x.

DOI:10.1111/j.1365-2133.1977.tb14275.x
PMID:603749
Abstract

Of 18 severely afffected vitiligo patients who used 20% monobenzylether of hydroquinone (MBEH, Benoquin) as a depigmenting agent, 8 achieved complete depigmentation after 10 months or more of use and 3 dramatic but no complete hypopigmentation. The 3 patients with no results did not use MBEH for more than 4 months. Complications were frequent particularly among those who did well, but only 1 case of contact dermatitis limited therapy. All patients who depigmented fully were very pleased with their results. As depigmentation induced by MBEH is generally irreversible, MBEH use must be reserved for induction of complete depigmentation of severely affected vitiligo patients who cannot or do not choose to repigment and who can accept the permanence of never tanning. The history, histology and mechanism of MBEH depigmentation are discussed.

摘要

在18名重度白癜风患者中,使用20%对苯二酚单苄醚(MBEH,白癜净)作为脱色剂,8名患者在使用10个月或更长时间后实现了完全脱色,3名患者出现显著但未完全的色素减退。3名无效果的患者使用MBEH的时间未超过4个月。并发症很常见,尤其是在效果良好的患者中,但仅有1例接触性皮炎限制了治疗。所有完全脱色的患者对结果都非常满意。由于MBEH诱导的脱色通常是不可逆的,MBEH的使用必须限于诱导重度白癜风患者完全脱色,这些患者无法或不选择重新色素沉着,并且能够接受永远不会晒黑的永久性。本文讨论了MBEH脱色的病史、组织学和机制。

相似文献

1
Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature.对苯二酚单苄醚。18例白癜风患者治疗的回顾性研究及文献综述。
Br J Dermatol. 1977 Dec;97(6):669-79. doi: 10.1111/j.1365-2133.1977.tb14275.x.
2
Retinoic acid synergistically enhances the melanocytotoxic and depigmenting effects of monobenzylether of hydroquinone in black guinea pig skin.维甲酸协同增强对苯二酚单苄醚在黑色豚鼠皮肤中的黑素细胞毒性和色素脱失作用。
Exp Dermatol. 2006 Jul;15(7):509-14. doi: 10.1111/j.1600-0625.2006.00441.x.
3
Depigmentation therapies for normal skin in vitiligo universalis.白癜风泛发性患者正常皮肤的脱色疗法。
J Eur Acad Dermatol Venereol. 2011 Jul;25(7):749-57. doi: 10.1111/j.1468-3083.2010.03876.x. Epub 2010 Nov 4.
4
Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation.对苯二酚单苄基醚和 4-叔丁基苯酚在黑素细胞中激活明显不同的生理反应:与皮肤脱色的相关性。
J Invest Dermatol. 2010 Jan;130(1):211-20. doi: 10.1038/jid.2009.214.
5
Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.强化漂白治疗:白癜风中免疫辅助黑素细胞自杀的机遇。
Exp Dermatol. 2014 Aug;23(8):529-33. doi: 10.1111/exd.12449. Epub 2014 Jul 10.
6
Rapid repigmentation after depigmentation therapy: vitiligo treated with monobenzyl ether of hydroquinone.色素脱失治疗后的快速色素再生:用对苯二酚单苄醚治疗白癜风。
Australas J Dermatol. 1996 May;37(2):96-8. doi: 10.1111/j.1440-0960.1996.tb01014.x.
7
Depigmentation Therapies for Vitiligo.白癜风的色素脱失治疗方法
Dermatol Clin. 2017 Apr;35(2):219-227. doi: 10.1016/j.det.2016.11.010.
8
Influence of depigmenting chemical agents on hair and skin color in yellow (pheomelanic) and black (eumelanic) mice.脱色化学试剂对黄色(褐黑素)和黑色(真黑素)小鼠毛发及皮肤颜色的影响。
Pigment Cell Res. 1990 Mar-Apr;3(2):71-9. doi: 10.1111/j.1600-0749.1990.tb00325.x.
9
Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser.泛发性白癜风采用外用4-甲氧基苯酚和Q开关红宝石激光进行色素脱失治疗。
J Am Acad Dermatol. 2000 May;42(5 Pt 1):760-9. doi: 10.1067/mjd.2000.103813.
10
Optimization of Monobenzone-Induced Vitiligo Mouse Model by the Addition of Chronic Stress.通过添加慢性应激优化单苯甲酮诱导的白癜风小鼠模型。
Int J Mol Sci. 2023 Apr 10;24(8):6990. doi: 10.3390/ijms24086990.

引用本文的文献

1
Vitiligo.白癜风
J Dtsch Dermatol Ges. 2025 Aug;23(8):968-987. doi: 10.1111/ddg.15706.
2
Vitiligo: Current Therapies and Future Treatments.白癜风:当前疗法与未来治疗
Dermatol Pract Concept. 2023 Dec 1;13(4S2):e2023313S. doi: 10.5826/dpc.1304S2a313S.
3
The use of lasers in vitiligo, an overview.激光在白癜风治疗中的应用概述。
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):779-789. doi: 10.1111/jdv.18005. Epub 2022 Mar 1.
4
Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial.单苯甲醚和咪喹莫特治疗黑色素瘤患者的抗黑色素瘤免疫及皮肤转移灶局部消退;一项2a期试验
Oncoimmunology. 2018 Jan 15;7(4):e1419113. doi: 10.1080/2162402X.2017.1419113. eCollection 2018.
5
Chemical-Induced Vitiligo.化学诱导性白癜风
Dermatol Clin. 2017 Apr;35(2):151-161. doi: 10.1016/j.det.2016.11.006.
6
Depigmentation with Q-switched Nd:YAG laser in universal vitiligo: a long-term follow-up study of 4 years.调Q开关Nd:YAG激光治疗泛发性白癜风的色素脱失:一项4年的长期随访研究
Lasers Med Sci. 2017 May;32(4):851-855. doi: 10.1007/s10103-017-2183-0. Epub 2017 Mar 7.
7
Understanding mechanisms of autoimmunity through translational research in vitiligo.通过白癜风的转化研究理解自身免疫机制。
Curr Opin Immunol. 2016 Dec;43:81-88. doi: 10.1016/j.coi.2016.09.008. Epub 2016 Oct 17.
8
Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo.干扰IFN-γ/CXCL10通路以开发白癜风的新型靶向治疗方法。
Ann Transl Med. 2015 Dec;3(21):343. doi: 10.3978/j.issn.2305-5839.2015.11.36.
9
Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo.器官特异性自身免疫中的细胞应激与先天性炎症:白癜风的经验教训
Immunol Rev. 2016 Jan;269(1):11-25. doi: 10.1111/imr.12369.
10
Concise review of recent studies in vitiligo.白癜风近期研究的简要综述。
Qatar Med J. 2013 Dec 23;2013(2):1-19. doi: 10.5339/qmj.2013.10. eCollection 2013.